Similarly, symptoms suggestive of gallbladder disease warrant investigation with liver function tests and abdominal ultrasonography
Documentation Summary for CDI Obesity Encounter Checklist For additional guidance on obesity coding, refer to the FY2026 ICD-10-CM Official Guidelines (CMS), the AHA Coding Clinic, and the American Society for Metabolic and Bariatric Surgery (ASMBS) clinical guidelines
Coverage depends on your state and whether it has chosen to cover obesity drugs
Use these codes when the encounter involves medication monitoring or education: Z51.81 Drug therapy monitoring Used for follow-ups, dose adjustments, and monitoring treatment response
This study was completed by two teams that worked independently, each composed of a clinician and research scientists, in collaboration with a researcher from Johns Hopkins